Totalt antall besøk

Visninger
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.270

Totalt antall besøk pr måned

september 2023oktober 2023november 2023desember 2023januar 2024februar 2024mars 2024
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.1411003

Nedlastinger av fil

Visninger
article.pdf226

Visninger pr land

Visninger
United States106
United Kingdom46
France26
Ireland18
Germany16
China9
Norge9
Vietnam9
Hong Kong SAR China5
Sweden5

Visninger pr by

Visninger
Ashburn55
Southend46
Dublin18
Ann Arbor11
Hanoi9
Oslo4
Dormagen3
Des Moines2
Mountain View2
Shanghai2